Prediction of aggregation rate and aggregation‐prone segments in polypeptide sequences

The reliable identification of β‐aggregating stretches in protein sequences is essential for the development of therapeutic agents for Alzheimer's and Parkinson's diseases, as well as other pathological conditions associated with protein deposition. Here, a model based on physicochemical properties and computational design of β‐aggregating peptide sequences is shown to be able to predict the aggregation rate over a large set of natural polypeptide sequences. Furthermore, the model identifies aggregation‐prone fragments within proteins and predicts the parallel or anti‐parallel β‐sheet organization in fibrils. The model recognizes different β‐aggregating segments in mammalian and nonmammalian prion proteins, providing insights into the species barrier for the transmission of the prion disease.

[1]  T. Paunio,et al.  In vitro expression analysis shows that the secretory form of gelsolin is the sole source of amyloid in gelsolin-related amyloidosis. , 1996, Human molecular genetics.

[2]  Susan Jones,et al.  Amyloid-forming peptides from beta2-microglobulin-Insights into the mechanism of fibril formation in vitro. , 2003, Journal of molecular biology.

[3]  Robert G Griffin,et al.  Molecular conformation of a peptide fragment of transthyretin in an amyloid fibril , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[4]  P. Lantos,et al.  Species-barrier-independent prion replication in apparently resistant species. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  W. Fitch,et al.  Construction of phylogenetic trees. , 1967, Science.

[6]  J. S. Sodhi,et al.  Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. , 2004, Journal of molecular biology.

[7]  D. Yee,et al.  Principles of protein folding — A perspective from simple exact models , 1995, Protein science : a publication of the Protein Society.

[8]  Ron D. Appel,et al.  ExPASy: the proteomics server for in-depth protein knowledge and analysis , 2003, Nucleic Acids Res..

[9]  Amedeo Caflisch,et al.  Organism complexity anti‐correlates with proteomic β‐aggregation propensity , 2005, Protein science : a publication of the Protein Society.

[10]  E. Mandelkow,et al.  Assembly of t protein into Alzheimer paired helical filaments depends on a local sequence motif ( 306 VQIVYK 311 ) forming b structure , 2000 .

[11]  Robert A. Grothe,et al.  An amyloid-forming peptide from the yeast prion Sup35 reveals a dehydrated β-sheet structure for amyloid , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Arthur L Horwich,et al.  Deadly Conformations—Protein Misfolding in Prion Disease , 1997, Cell.

[13]  R. Leapman,et al.  Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance. , 2002, Biochemistry.

[14]  M. O. Dayhoff,et al.  Atlas of protein sequence and structure , 1965 .

[15]  A. Fersht.  Structure and mechanism in protein science , 1998 .

[16]  A. Cavalli,et al.  The role of aromaticity, exposed surface, and dipole moment in determining protein aggregation rates , 2004, Protein science : a publication of the Protein Society.

[17]  J. J. Balbach,et al.  Increasing the amphiphilicity of an amyloidogenic peptide changes the beta-sheet structure in the fibrils from antiparallel to parallel. , 2004, Biophysical journal.

[18]  Christopher M. Dobson,et al.  The protofilament structure of insulin amyloid fibrils , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[20]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[21]  T. Hashikawa,et al.  Intra- and Intermolecular β-Pleated Sheet Formation in Glutamine-repeat Inserted Myoglobin as a Model for Polyglutamine Diseases* , 2001, The Journal of Biological Chemistry.

[22]  J. Apostolakis,et al.  Evaluation of a fast implicit solvent model for molecular dynamics simulations , 2002, Proteins.

[23]  W. Surewicz,et al.  Molecular basis of barriers for interspecies transmissibility of mammalian prions. , 2004, Molecular cell.

[24]  U. Bornscheuer,et al.  Protein Engineering , 2018, Methods in Molecular Biology.

[25]  L. Serrano,et al.  Prediction of sequence-dependent and mutational effects on the aggregation of peptides and proteins , 2004, Nature Biotechnology.

[26]  M. Hecht,et al.  Nature disfavors sequences of alternating polar and non-polar amino acids: implications for amyloidogenesis. , 2000, Journal of molecular biology.

[27]  M. Kirkitadze,et al.  Amyloid β-protein (Aβ) assembly: Aβ40 and Aβ42 oligomerize through distinct pathways , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[28]  J. Kelly,et al.  The alternative conformations of amyloidogenic proteins and their multi-step assembly pathways. , 1998, Current opinion in structural biology.

[29]  Marc S. Cortese,et al.  Comparing and combining predictors of mostly disordered proteins. , 2005, Biochemistry.

[30]  J. Castilla,et al.  The controversial protein-only hypothesis of prion propagation , 2004, Nature Medicine.

[31]  Ehud Gazit,et al.  Analysis of the Minimal Amyloid-forming Fragment of the Islet Amyloid Polypeptide , 2001, The Journal of Biological Chemistry.

[32]  L. Serrano,et al.  A comparative study of the relationship between protein structure and beta-aggregation in globular and intrinsically disordered proteins. , 2004, Journal of molecular biology.

[33]  R. Leapman,et al.  Multiple quantum solid-state NMR indicates a parallel, not antiparallel, organization of β-sheets in Alzheimer's β-amyloid fibrils , 2000 .

[34]  S L Mayo,et al.  Intrinsic beta-sheet propensities result from van der Waals interactions between side chains and the local backbone. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[35]  G. McGaughey,et al.  pi-Stacking interactions. Alive and well in proteins. , 1998, The Journal of biological chemistry.

[36]  F E Cohen,et al.  Prion protein peptides induce alpha-helix to beta-sheet conformational transitions. , 1995, Biochemistry.

[37]  Lars Terenius,et al.  A Molecular Model of Alzheimer Amyloid β-Peptide Fibril Formation* , 1999, The Journal of Biological Chemistry.

[38]  M. Nadeau.  Proteins : Structure , Function , and Genetics , 2022 .

[39]  Ehud Gazit,et al.  A possible role for π‐stacking in the self‐assembly of amyloid fibrils , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[40]  P. Westermark,et al.  The N-terminal segment of protein AA determines its fibrillogenic property. , 1992, Biochemical and biophysical research communications.

[41]  J. Liepnieks,et al.  Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. , 1988, Biochemical and biophysical research communications.

[42]  Hans Lehrach,et al.  Huntingtin-Encoded Polyglutamine Expansions Form Amyloid-like Protein Aggregates In Vitro and In Vivo , 1997, Cell.

[43]  E. Mandelkow,et al.  Assembly of tau protein into Alzheimer paired helical filaments depends on a local sequence motif ((306)VQIVYK(311)) forming beta structure. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Fabrizio Chiti,et al.  Studies of the aggregation of mutant proteins in vitro provide insights into the genetics of amyloid diseases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Murata,et al.  Amyloid‐like aggregates of a plant protein: a case of a sweet‐tasting protein, monellin , 1999, FEBS letters.

[46]  E. Masliah,et al.  Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[47]  R. Pickersgill,et al.  The architecture of parallel β-helices and related folds , 2001 .

[48]  Susan Budavari,et al.  The Merck index , 1998 .

[49]  C. Dobson,et al.  Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases , 2002, Nature.

[50]  Eric R. Kandel,et al.  Two previously undescribed members of the mouse CPEB family of genes and their inducible expression in the principal cell layers of the hippocampus , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[51]  E. Koonin,et al.  The structure of the protein universe and genome evolution , 2002, Nature.

[52]  V. Uversky,et al.  Conformational prerequisites for formation of amyloid fibrils from histones. , 2004, Journal of molecular biology.

[53]  Zoran Obradovic,et al.  The Protein Non-Folding Problem: Amino Acid Determinants of Intrinsic Order and Disorder , 2000, Pacific Symposium on Biocomputing.

[54]  S. Prusiner,et al.  Prion diseases and the BSE crisis. , 1997, Science.

[55]  L. Iakoucheva,et al.  Intrinsic Disorder and Protein Function , 2002 .

[56]  J. W. COOK,et al.  “The Merck Index” , 1953, Nature.

[57]  A. Caflisch,et al.  The role of side-chain interactions in the early steps of aggregation: Molecular dynamics simulations of an amyloid-forming peptide from the yeast prion Sup35 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[58]  L. Tjernberg,et al.  Medin: an integral fragment of aortic smooth muscle cell-produced lactadherin forms the most common human amyloid. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[59]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[60]  J. Carpenter,et al.  Partial molar volume, surface area, and hydration changes for equilibrium unfolding and formation of aggregation transition state: High-pressure and cosolute studies on recombinant human IFN-γ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  E. F. ARMSTRONG,et al.  Annual Review of Biochemistry , 1944, Nature.

[62]  A. Fersht,et al.  Rapid amyloid fiber formation from the fast-folding WW domain FBP28 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  L. Tjernberg,et al.  Charge Attraction and β Propensity Are Necessary for Amyloid Fibril Formation from Tetrapeptides* , 2002, The Journal of Biological Chemistry.

[64]  F M Richards,et al.  An analysis of packing in the protein folding problem , 1993, Quarterly Reviews of Biophysics.

[65]  C. Dobson.  Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[66]  C. Dobson,et al.  Rationalization of the effects of mutations on peptide andprotein aggregation rates , 2003, Nature.

[67]  George B. Benedek,et al.  Kinetic theory of fibrillogenesis of amyloid β-protein , 1997 .

[68]  Clive P. Page,et al.  Trends in Pharmacological Sciences , 1989 .

[69]  B. Austen,et al.  Effect of the disulfide bridge and the C-terminal extension on the oligomerization of the amyloid peptide ABri implicated in familial British dementia. , 2001, Biochemistry.

[70]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  O. Quarrell.  Glutamine repeats and neurodegenerative diseases: molecular aspects , 2001, Human Genetics.

[72]  Ralf Langen,et al.  Template-assisted filament growth by parallel stacking of tau. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[73]  D. Kirschner,et al.  On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[74]  F. Young.  Biochemistry , 1955, The Indian Medical Gazette.

[75]  Ying Xu,et al.  Mapping abeta amyloid fibril secondary structure using scanning proline mutagenesis. , 2004, Journal of molecular biology.

[76]  Minoru Katō,et al.  Chain‐length dependence of α‐helix to β‐sheet transition in polylysine: Model of protein aggregation studied by temperature‐tuned FTIR spectroscopy , 2004 .

[77]  B. Rost,et al.  Loopy proteins appear conserved in evolution. , 2002, Journal of molecular biology.

[78]  Pawel Sikorski,et al.  Molecular basis for amyloid fibril formation and stability. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[79]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[80]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[81]  J. Thompson,et al.  CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. , 1994, Nucleic acids research.

[82]  A. Fersht,et al.  Energetics of complementary side-chain packing in a protein hydrophobic core. , 1989, Biochemistry.

[83]  M. Kirkitadze,et al.  Amyloid b-protein (Ab) assembly: Ab40 and Ab42 oligomerize through distinct pathways , 2003 .

[84]  C. Dobson,et al.  Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution , 2003, Journal of Molecular Medicine.

[85]  M. F.,et al.  Bibliography , 1985, Experimental Gerontology.

[86]  E. Kandel,et al.  A Neuronal Isoform of the Aplysia CPEB Has Prion-Like Properties , 2003, Cell.

[87]  Olivier Michielin,et al.  Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors , 2003, J. Comput. Aided Mol. Des..

[88]  J. Weissman,et al.  A census of glutamine/asparagine-rich regions: implications for their conserved function and the prediction of novel prions. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[89]  J. Bernhagen,et al.  Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. , 1999, Journal of molecular biology.

[90]  J. Bernhagen,et al.  Identification of a penta- and hexapeptide of islet amyloid polypeptide (IAPP) with amyloidogenic and cytotoxic properties. , 2000, Journal of molecular biology.

[91]  D Eisenberg,et al.  Chicken prion tandem repeats form a stable, protease-resistant domain. , 1999, Biochemistry.

[92]  M. A. Soto,et al.  On the Construction of a Phylogenetic Tree , 1979 .

[93]  Eric R. Kandel,et al.  A Neuronal Isoform of CPEB Regulates Local Protein Synthesis and Stabilizes Synapse-Specific Long-Term Facilitation in Aplysia , 2003, Cell.

[94]  T. Huppert,et al.  Chain length dependence of apomyoglobin folding: structural evolution from misfolded sheets to native helices. , 2003, Biochemistry.

[95]  D. Matthews,et al.  The potential for transmissible spongiform encephalopathies in non-ruminant livestock and fish. , 2003, Revue scientifique et technique.

[96]  M. Tanner.  Trends in Biochemical Sciences , 1982 .

[97]  D. W. Hayden,et al.  Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[98]  George B. Benedek,et al.  Temperature dependence of amyloid β-protein fibrillization , 1998 .

[99]  Roger D Kamm,et al.  Kinetic control of dimer structure formation in amyloid fibrillogenesis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[100]  J. A. V. BUTLER,et al.  Advances in Protein Chemistry , 1946, Nature.

[101]  Ralf Langen,et al.  Structural and Dynamic Features of Alzheimer's Aβ Peptide in Amyloid Fibrils Studied by Site-directed Spin Labeling* , 2002, The Journal of Biological Chemistry.

[102]  K. Wüthrich,et al.  Prion-inducing domain 2-114 of yeast Sup35 protein transforms in vitro into amyloid-like filaments. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[103]  A. Miranker,et al.  Islet amyloid: phase partitioning and secondary nucleation are central to the mechanism of fibrillogenesis. , 2002, Biochemistry.

[104]  J. Weissman,et al.  The utility of prions. , 2002, Developmental cell.

[105]  S. Aota,et al.  Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module. , 1998, Journal of molecular biology.

[106]  J. Liepnieks,et al.  Renal amyloidosis with a frame shift mutation in fibrinogen aalpha-chain gene producing a novel amyloid protein. , 1997, Blood.

[107]  E. Gazit,et al.  Completely different amyloidogenic potential of nearly identical peptide fragments. , 2003, Biopolymers.

[108]  Francesca Massi,et al.  Energy landscape theory for Alzheimer's amyloid β‐peptide fibril elongation , 2001 .

[109]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[110]  Michele Vendruscolo,et al.  Prediction of the absolute aggregation rates of amyloidogenic polypeptide chains. , 2004, Journal of molecular biology.

[111]  A. Mazur,et al.  Sheep Prion Protein Synthetic Peptide Spanning Helix 1 and β-Strand 2 (Residues 142–166) Shows β-Hairpin Structure in Solution* , 2001, The Journal of Biological Chemistry.

[112]  D. Kirschner,et al.  Assemblies of Alzheimer’s peptides Aβ25–35 and Aβ31–35: reverse-turn conformation and side-chain interactions revealed by X-ray diffraction , 2003 .